KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

Nektar Therapeutics (NKTR) Receivables - Net (2016 - 2025)

Nektar Therapeutics has reported Receivables - Net over the past 16 years, most recently at $400000.0 for Q4 2025.

  • Quarterly results put Receivables - Net at $400000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $400000.0 (changed N/A YoY), and the annual figure for FY2025 was $400000.0, changed.
  • Receivables - Net for Q4 2025 was $400000.0 at Nektar Therapeutics, up from $200000.0 in the prior quarter.
  • Over the last five years, Receivables - Net for NKTR hit a ceiling of $30.2 million in Q1 2022 and a floor of $200000.0 in Q3 2025.
  • Median Receivables - Net over the past 5 years was $4.8 million (2022), compared with a mean of $11.3 million.
  • Biggest five-year swings in Receivables - Net: crashed 90.09% in 2023 and later increased 20.77% in 2024.
  • Nektar Therapeutics' Receivables - Net stood at $22.5 million in 2021, then plummeted by 73.41% to $6.0 million in 2022, then tumbled by 79.85% to $1.2 million in 2023, then decreased by 0.75% to $1.2 million in 2024, then plummeted by 66.56% to $400000.0 in 2025.
  • The last three reported values for Receivables - Net were $400000.0 (Q4 2025), $200000.0 (Q3 2025), and $1.2 million (Q2 2024) per Business Quant data.